New AMP CMD funding opportunities

The Foundation for the National Institutes of Health (FNIH) has issued two new requests for proposals for the Accelerating Medicines Partnership® in Common Metabolic Diseases (AMP® CMD). RFP5 seeks proposals for generating 'omic and multi-omic results in tissues relevant to common metabolic diseases, while RFP6 will fund generation of 'omic and multi-omic results in the same tissues, specifically in non-European ancestry cohorts. Results from the funded proposals will be incorporated into the Common Metabolic Diseases Genome Atlas and/or the Common Metabolic Diseases Knowledge Portal. Proposals are due by April 3, 2024.

md, t2d, t1d, cd, cvd, sleep